Aspen Pharmacare - 15 Year Stock Price History | APNHY
Historical daily share price chart and data for Aspen Pharmacare since 2011 adjusted for splits and dividends. The latest closing stock price for Aspen Pharmacare as of June 04, 2026 is 8.87.
- The all-time high Aspen Pharmacare stock closing price was 33.68 on January 26, 2015.
- The Aspen Pharmacare 52-week high stock price is 8.93, which is 0.7% above the current share price.
- The Aspen Pharmacare 52-week low stock price is 5.30, which is 40.2% below the current share price.
- The average Aspen Pharmacare stock price for the last 52 weeks is 6.82.
| Aspen Pharmacare Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 7.8831 | 6.5800 | 8.9340 | 6.5800 | 8.8700 | 25.85% |
| 2025 | 6.9399 | 8.2600 | 9.9400 | 5.3000 | 7.0480 | -17.53% |
| 2024 | 10.8587 | 10.4021 | 13.2943 | 8.5462 | 8.5462 | -20.02% |
| 2023 | 8.9455 | 7.5784 | 10.6854 | 7.2736 | 10.6854 | 41.74% |
| 2022 | 9.5303 | 12.7106 | 13.6234 | 6.8407 | 7.5389 | -41.68% |
| 2021 | 11.3225 | 7.7643 | 16.7112 | 7.6507 | 12.9276 | 66.66% |
| 2020 | 6.8409 | 7.9088 | 8.1288 | 4.5515 | 7.7570 | 0.10% |
| 2019 | 6.7848 | 8.2869 | 10.3173 | 3.8517 | 7.7489 | -9.03% |
| 2018 | 15.7771 | 19.5558 | 21.2506 | 8.0751 | 8.5178 | -57.38% |
| 2017 | 19.2673 | 18.0581 | 21.6028 | 17.5028 | 19.9838 | 9.14% |
| 2016 | 18.9922 | 16.2674 | 25.0805 | 13.7526 | 18.3098 | 4.66% |
| 2015 | 25.1127 | 30.1750 | 33.6816 | 16.5845 | 17.4947 | -42.43% |
| 2014 | 24.7898 | 22.1671 | 32.7945 | 18.8067 | 30.3907 | 34.75% |
| 2013 | 19.7076 | 16.0095 | 24.2790 | 15.6431 | 22.5530 | 33.44% |
| 2012 | 13.7021 | 10.8350 | 16.9014 | 10.8350 | 16.9014 | 72.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $3.708B | $2.388B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |